{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:02:47Z","timestamp":1787580167149,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"vor","delay-in-days":355,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ajpath.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T21:42:06Z","timestamp":1380577326000},"page":"1390-1396","source":"Crossref","is-referenced-by-count":76,"title":["Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis"],"prefix":"10.1016","volume":"183","author":[{"given":"Fumitaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.07.006_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.07.006_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.07.006_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jcp.22138","article-title":"Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats","volume":"224","author":"Palsamy","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib4","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.07.006_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nbt0310-185","article-title":"GSK\/Sirtris compounds dogged by assay artifacts","volume":"28","author":"Schmidt","year":"2010","journal-title":"Nature Biotechnol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib6","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1074\/jbc.M500655200","article-title":"Substrate-specific activation of sirtuins by resveratrol","volume":"280","author":"Kaeberlein","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.07.006_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1747-0285.2009.00901.x","article-title":"Resveratrol is not a direct activator of SIRT1 enzyme activity","volume":"74","author":"Beher","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.ajpath.2013.07.006_bib8","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1","volume":"285","author":"Pacholec","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.07.006_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/01.wnl.0000250267.85698.7a","article-title":"Gray matter involvement in multiple sclerosis","volume":"68","author":"Pirko","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pathophys.2012.03.003","article-title":"Immunopathological patterns from EAE and Theiler\u2019s virus infection: is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?","volume":"20","author":"Martinez","year":"2013","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pneurobio.2012.11.003","article-title":"Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler\u2019s virus","volume":"101\u2013102","author":"Mecha","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib12","first-page":"55","article-title":"Animal models of multiple sclerosis. Neuroinflammation","author":"Sato","year":"2011"},{"key":"10.1016\/j.ajpath.2013.07.006_bib13","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/jn\/136.10.2542","article-title":"Resveratrol is rapidly metabolized in athymic (nu\/nu) mice and does not inhibit human melanoma xenograft tumor growth","volume":"136","author":"Niles","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.ajpath.2013.07.006_bib14","first-page":"4945","article-title":"Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-\u03baB, cyclooxygenase 2, and matrix metalloprotease 9","volume":"62","author":"Banerjee","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.07.006_bib15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","article-title":"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials [Erratum appeared in Lancet 2004, 363:662]","volume":"361","author":"Vivekananthan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2013.07.006_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2007.08.003","article-title":"Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes","volume":"577","author":"Campos-Toimil","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib17","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.4049\/jimmunol.1001043","article-title":"Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-\u03baB activation and peroxisome proliferator-activated receptor-gamma upregulation","volume":"185","author":"Rius","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib18","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10895-011-0886-3","article-title":"Activation energy of light induced isomerization of resveratrol","volume":"21","author":"Figueiras","year":"2011","journal-title":"J Fluoresc"},{"key":"10.1016\/j.ajpath.2013.07.006_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1358\/mf.2001.23.5.662120","article-title":"Protective effect of resveratrol against intracortical FeCl3-induced model of posttraumatic seizures in rats","volume":"23","author":"Gupta","year":"2001","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0891-5849(02)00911-5","article-title":"Inhibition of cancer growth by resveratrol is related to its low bioavailability","volume":"33","author":"Asensi","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajpath.2013.07.006_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tox.2006.05.011","article-title":"Comparative study of natural antioxidants\u2014curcumin, resveratrol and melatonin\u2014in cadmium-induced oxidative damage in mice","volume":"225","author":"Eybl","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib22","unstructured":"GlaxoSmithKline halts all further development of resveratrol drug SRT501. The Myeloma Beacon 2010 Nov 30 [Internet]. Available at http:\/\/www.myelomabeacon.com\/news\/2010\/11\/30\/glaxosmithkline-halts-all-further-development-of-resveratrol-drug-srt501, last revised November 30, 2010"},{"key":"10.1016\/j.ajpath.2013.07.006_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2353\/ajpath.2007.060683","article-title":"Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: when can axonal injury be beneficial?","volume":"170","author":"Tsunoda","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib24","doi-asserted-by":"crossref","first-page":"10279","DOI":"10.1128\/JVI.00734-08","article-title":"Regulatory role of CD1d in neurotropic virus infection","volume":"82","author":"Tsunoda","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib25","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1128\/JVI.75.16.7494-7505.2001","article-title":"Prolonged gray matter disease without demyelination caused by Theiler\u2019s murine encephalomyelitis virus with a mutation in VP2 puff B","volume":"75","author":"Tsunoda","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)63922-3","article-title":"Axonal injury heralds virus-induced demyelination","volume":"162","author":"Tsunoda","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pathophys.2010.04.011","article-title":"Theiler\u2019s virus infection: pathophysiology of demyelination and neurodegeneration","volume":"18","author":"Sato","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1017\/S0007114509993485","article-title":"Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health","volume":"103","author":"Nicholson","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ajpath.2013.07.006_bib29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","article-title":"Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale","volume":"64","author":"Rice","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","article-title":"Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system","volume":"85","author":"Steinman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.07.006_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1471-4914(00)01909-2","article-title":"Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy","volume":"7","author":"Lassmann","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ajpath.2013.07.006_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.07.006_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1750-3639.2006.00042.x","article-title":"Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade","volume":"17","author":"Tsunoda","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib34","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4\u2032-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor","volume":"72","author":"Singh","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.intimp.2008.10.015","article-title":"Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(\u2212) IFN-gamma+ cells, and decreased macrophage IL-6 expression","volume":"9","author":"Imler","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fneur.2012.00084","article-title":"Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis","volume":"3","author":"Fonseca-Kelly","year":"2012","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.410260218","article-title":"Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis","volume":"26","author":"Bergstr\u00f6m","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2013.07.006_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.42.2.278","article-title":"Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection","volume":"42","author":"Bray","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2013.07.006_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2006.06.011","article-title":"Resveratrol suppresses nuclear factor-\u03baB in herpes simplex virus infected cells","volume":"72","author":"Faith","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajpath.2013.07.006_bib40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/phrs.2002.0992","article-title":"Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis","volume":"45","author":"Kapadia","year":"2002","journal-title":"Pharmacol Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T06:00:02Z","timestamp":1564207202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013005270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0002944013005270"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.07.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}